168 related articles for article (PubMed ID: 36066432)
1. DRviaSPCN: a software package for drug repurposing in cancer via a subpathway crosstalk network.
Wu J; Li X; Wang Q; Han J
Bioinformatics; 2022 Oct; 38(21):4975-4977. PubMed ID: 36066432
[TBL] [Abstract][Full Text] [Related]
2. SubtypeDrug: a software package for prioritization of candidate cancer subtype-specific drugs.
Han X; Kong Q; Liu C; Cheng L; Han J
Bioinformatics; 2021 Aug; 37(16):2491-2493. PubMed ID: 33459772
[TBL] [Abstract][Full Text] [Related]
3. psSubpathway: a software package for flexible identification of phenotype-specific subpathways in cancer progression.
Han J; Han X; Kong Q; Cheng L
Bioinformatics; 2020 Apr; 36(7):2303-2305. PubMed ID: 31821408
[TBL] [Abstract][Full Text] [Related]
4. Prioritization of candidate cancer drugs based on a drug functional similarity network constructed by integrating pathway activities and drug activities.
Di J; Zheng B; Kong Q; Jiang Y; Liu S; Yang Y; Han X; Sheng Y; Zhang Y; Cheng L; Han J
Mol Oncol; 2019 Oct; 13(10):2259-2277. PubMed ID: 31408580
[TBL] [Abstract][Full Text] [Related]
5. A novel computational approach for drug repurposing using systems biology.
Peyvandipour A; Saberian N; Shafi A; Donato M; Draghici S
Bioinformatics; 2018 Aug; 34(16):2817-2825. PubMed ID: 29534151
[TBL] [Abstract][Full Text] [Related]
6. CNA2Subpathway: identification of dysregulated subpathway driven by copy number alterations in cancer.
Sheng Y; Jiang Y; Yang Y; Li X; Qiu J; Wu J; Cheng L; Han J
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33423051
[TBL] [Abstract][Full Text] [Related]
7. wTO: an R package for computing weighted topological overlap and a consensus network with integrated visualization tool.
Gysi DM; Voigt A; Fragoso TM; Almaas E; Nowick K
BMC Bioinformatics; 2018 Oct; 19(1):392. PubMed ID: 30355288
[TBL] [Abstract][Full Text] [Related]
8. DrugSim2DR: systematic prediction of drug functional similarities in the context of specific disease for drug repurposing.
Wu J; Li J; He Y; Huang J; Zhao X; Pan B; Wang Y; Cheng L; Han J
Gigascience; 2022 Dec; 12():. PubMed ID: 38116825
[TBL] [Abstract][Full Text] [Related]
9. Repurposing drugs in oncology: From candidate selection to clinical adoption.
Pantziarka P; Verbaanderd C; Huys I; Bouche G; Meheus L
Semin Cancer Biol; 2021 Jan; 68():186-191. PubMed ID: 31982510
[TBL] [Abstract][Full Text] [Related]
10. Breaking the paradigm: Dr Insight empowers signature-free, enhanced drug repurposing.
Chan J; Wang X; Turner JA; Baldwin NE; Gu J
Bioinformatics; 2019 Aug; 35(16):2818-2826. PubMed ID: 30624606
[TBL] [Abstract][Full Text] [Related]
11. DEsubs: an R package for flexible identification of differentially expressed subpathways using RNA-seq experiments.
Vrahatis AG; Balomenos P; Tsakalidis AK; Bezerianos A
Bioinformatics; 2016 Dec; 32(24):3844-3846. PubMed ID: 27542770
[TBL] [Abstract][Full Text] [Related]
12. A network-based drug repurposing method via non-negative matrix factorization.
Sadeghi S; Lu J; Ngom A
Bioinformatics; 2022 Feb; 38(5):1369-1377. PubMed ID: 34875000
[TBL] [Abstract][Full Text] [Related]
13. Cancer driver drug interaction explorer.
Hartung M; Anastasi E; Mamdouh ZM; Nogales C; Schmidt HHHW; Baumbach J; Zolotareva O; List M
Nucleic Acids Res; 2022 Jul; 50(W1):W138-W144. PubMed ID: 35580047
[TBL] [Abstract][Full Text] [Related]
14. Computer-aided drug repurposing for cancer therapy: Approaches and opportunities to challenge anticancer targets.
Mottini C; Napolitano F; Li Z; Gao X; Cardone L
Semin Cancer Biol; 2021 Jan; 68():59-74. PubMed ID: 31562957
[TBL] [Abstract][Full Text] [Related]
15. Old drugs, new uses: Drug repurposing in hematological malignancies.
Kale VP; Habib H; Chitren R; Patel M; Pramanik KC; Jonnalagadda SC; Challagundla K; Pandey MK
Semin Cancer Biol; 2021 Jan; 68():242-248. PubMed ID: 32151704
[TBL] [Abstract][Full Text] [Related]
16. RANKS: a flexible tool for node label ranking and classification in biological networks.
Valentini G; Armano G; Frasca M; Lin J; Mesiti M; Re M
Bioinformatics; 2016 Sep; 32(18):2872-4. PubMed ID: 27256314
[TBL] [Abstract][Full Text] [Related]
17. Implementation of a Pipeline Using Disease-Disease Associations for Computational Drug Repurposing.
Balasundaram P; Kanagavelu R; James N; Maiti S; Veerappapillai S; Karuppaswamy R
Methods Mol Biol; 2019; 1903():129-148. PubMed ID: 30547440
[TBL] [Abstract][Full Text] [Related]
18. gene2drug: a computational tool for pathway-based rational drug repositioning.
Napolitano F; Carrella D; Mandriani B; Pisonero-Vaquero S; Sirci F; Medina DL; Brunetti-Pierri N; di Bernardo D
Bioinformatics; 2018 May; 34(9):1498-1505. PubMed ID: 29236977
[TBL] [Abstract][Full Text] [Related]
19. Repurposing Drugs in Oncology: Next Steps.
Verbaanderd C; Meheus L; Huys I; Pantziarka P
Trends Cancer; 2017 Aug; 3(8):543-546. PubMed ID: 28780930
[TBL] [Abstract][Full Text] [Related]
20. Drug repurposing for cancer therapy, easier said than done.
Gonzalez-Fierro A; Dueñas-González A
Semin Cancer Biol; 2021 Jan; 68():123-131. PubMed ID: 31877340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
